Outcomes of 881 Consecutive Coronary Artery Bypass Graft Patients Using Heartstring Device

Kentaro Amano1, Yoshiyuki Takami1, Atsuo Maekawa1

  • 1Department of Cardiovascular Surgery, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

Insights

Using the Heartstring device for coronary artery bypass grafting (CABG) is a valid strategy to prevent stroke. This method demonstrated a low perioperative stroke rate of 0.9%, contributing to improved long-term patient prognosis.

Area of Science:

  • Cardiovascular Surgery
  • Neurosurgery
  • Medical Devices

Background:

  • Stroke is a significant risk following coronary artery bypass grafting (CABG).
  • Minimally invasive aortic manipulation techniques are sought to reduce perioperative complications.
  • The Heartstring device offers a method for proximal anastomosis without aortic clamping.

Purpose of the Study:

  • To evaluate the early and late outcomes of isolated CABG using the Heartstring device.
  • To determine the validity and safety of the Heartstring device in preventing stroke during CABG.
  • To assess the impact of this technique on long-term prognosis.

Main Methods:

  • Retrospective investigation of 881 consecutive patients undergoing isolated CABG with the Heartstring device (January 2008 - December 2022).
  • Preoperative imaging to assess neurovascular atherosclerosis in all patients.
  • Analysis of early outcomes (in-hospital mortality, perioperative stroke) and late outcomes (survival, MACCEs).

Main Results:

  • The study included 881 patients with a mean age of 68.9 years; 20% were female, and 13% had a prior stroke history.
  • In-hospital mortality was 2.0%, and the perioperative stroke rate was 0.9%.
  • At 5 and 10 years, actuarial survival rates were 86% and 66%, respectively. Major adverse cardiac and cerebrovascular events (MACCEs)-free rates were 86% and 70% at 5 and 10 years.

Conclusions:

  • The Heartstring device for proximal anastomosis during CABG is associated with a low stroke rate (0.9%).
  • This technique may contribute to improved long-term survival and reduced MACCEs after CABG.
  • The findings support the validity of using the Heartstring device to mitigate stroke risk in CABG patients.
Abstract

Related Concept Videos